NTBFs
Starting: 2016
FOCUS:
Discovery of innovative «first-in-class» therapies, based on the principle of pharmacological chaperones, for the treatment of rare and ultra-rare diseases. 1 ODD (EMA & FDA) finishing Phase I in USA
FOCUS:
Discovery of innovative «first-in-class» therapies, based on the principle of pharmacological chaperones, for the treatment of rare and ultra-rare diseases. 1 ODD (EMA & FDA) finishing Phase I in USA
Starting: 2020
FOCUS:
Reseach and development of Biomedical Projects, Biological & Medical Data Analitics
Starting: June 2022
FOCUS:
Advanced Therapy, CAR-T & Biologics (Antibody Therapy) for solid tumors
FOCUS:
Advanced Therapy, CAR-T & Biologics (Antibody Therapy) for solid tumors